The NADA Practice Leadership Group (NPLG) met for their quarterly meeting in September 2018 where new members of the NPLG met and quickly dove into it. Work is being done around progressing the recommendations from the withdrawal management paper, salary benchmarking for common positions within the AOD sector, and the NPLG is at the early stages of planning for an access and equity forum.
The following messages arose from the meeting:
NPLG advocates for streamlining and standardising forms for easier access and greater equity for clients.
NPLG places importance on investing more in the sector and for consideration around the need for a focus on workforce development and increasing workforce.
NPLG finds it vitally important that the sector think about a staff exchange and how that would work to provide an immersion experience for staff to understand the different treatment types within the AOD sector.
Ask the NPLG for advice
Help your service deliver person centred and evidence based practices to improve the wellbeing of clients and their networks of support. Learn about each member, their area of expertise and their interest. Email NPLG@nada.org.au or phone Suzie Hudson on 8113 1309 to ask for support.
Enhancing clinical practice—3 May 2017
Connecting clinical practice leaders in the NSW non government alcohol and other drug sector for the purpose of increasing the capacity of service providers to deliver person centred, evidence based practices to improve the wellbeing of clients and their networks of support.
The NPLG was established in July 2015 and now comprise 11 members representing a variety of specialist non government AOD treatment services. All members are clinical practitioners and considered leaders in the sector as evidenced by their professional backgrounds, accreditation status and clinical experience.
The group meet four times a year and meetings are open to other members/organisations as guest speakers only by invitation.
The overall aim of the NPLG is to inform the development of NADA policy and advocacy, and sector program development in relation to sector clinical and therapeutic practices. It will provide a mechanism to consult with experienced, committed and skilled practitioners to advise NADA and other key stakeholders.